Market capitalization | $190.51b |
Enterprise Value | $186.38b |
P/E (TTM) P/E ratio | 85.97 |
EV/FCF (TTM) EV/FCF | 318.05 |
EV/Sales (TTM) EV/Sales | 23.69 |
P/S ratio (TTM) P/S ratio | 24.22 |
P/B ratio (TTM) P/B ratio | 12.23 |
Revenue growth (TTM) Revenue growth | 14.83% |
Revenue (TTM) Revenue | $7.87b |
Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.
33 Analysts have issued a Intuitive Surgical forecast:
33 Analysts have issued a Intuitive Surgical forecast:
Sep '24 |
+/-
%
|
||
Revenue | 7,867 7,867 |
15%
15%
|
|
Gross Profit | 5,269 5,269 |
16%
16%
|
|
EBITDA | 2,516 2,516 |
20%
20%
|
EBIT (Operating Income) EBIT | 2,064 2,064 |
22%
22%
|
Net Profit | 2,243 2,243 |
48%
48%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
Head office | United States |
CEO | Gary Guthart |
Employees | 13,676 |
Founded | 1995 |
Website | www.intuitive.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.